Congress enacted the fiscal year 2026 Labor, Health and Human Services, Education, and Related Agencies (LHHS) appropriations bill, providing ...

Sustained interest in small molecules, bispecific antibodies, and genomics got the ball rolling in the biotech deals arena in ...

Charlie Paterson, partner at PA Consulting, explains how mixed signals on FDA risk tolerance are accelerating the ...

Trump first revealed his administration's goal of launching the website back in September when he announced that Pfizer had ...

Trump launches TrumpRx.gov offering discounted prescription drugs for cash-paying patients, aiming to lower drug prices ...

As Priovant works toward approval of potential blockbuster brepocitinib as a treatment for dermatomyositis, the North ...

The Forestry Development Authority's (FDA) decision to halt the gazettement of the proposed Foya National Park has ignited a fresh debate over the future of forest conservation in Liberia, raising ...

TrumpRx is aimed at helping patients use their own money to buy medicines. But researchers who study drug pricing warned that ...

Q1 2026 Management View Dr. Christopher Anzalone, Chairman, CEO & President, stated, "We had another quarter of strong execution across all areas of our business, and we are well positioned to build ...

NTLA stock faces binary risk: success could unlock multi-billion dollar markets, while setbacks may erase hundreds of ...

Q: How can I keep my brain healthy as I get older? Dr. Cordia Wan, Inpatient Neurology, Pacific Permanente Group: You can’t ...